Zydus receives final approval from USFDA for Itraconazole Capsules

21 Sep 2017 Evaluate

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Itraconazole Capsules 100 mg. The drug is used to treat a variety of fungal infections and will be manufactured at the group’s formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 150 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Zydus Lifesciences Share Price

907.45 -2.55 (-0.28%)
17-Feb-2026 12:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.35
Dr. Reddys Lab 1269.85
Cipla 1346.30
Zydus Lifesciences 907.45
Lupin 2248.90
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×